Horacio Grecco-Fernandez
Sanatorio Municipal Dr. Julio Méndez
B, Argentina
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Journal: Cancer immunology, immunotherapy : CII
Published: February 08, 2021
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.
Journal: Haematologica
Published: October 15, 2020
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.
Journal: Frontiers in oncology
Published: August 24, 2020
The effect of ibrutinib on neutrophil and γδ T cell functions.
Journal: Leukemia & lymphoma
Published: April 21, 2020
Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils.
Journal: American journal of hematology
Published: January 29, 2020
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: July 16, 2019
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Journal: Haematologica
Published: May 12, 2018
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16high CD62Ldim immunosuppressive subset.
Journal: International journal of cancer
Published: January 29, 2018
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Journal: Scientific reports
Published: August 02, 2017
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Journal: Cancer immunology, immunotherapy : CII
Published: June 26, 2016
Last Updated: 09/26/2026